Kiss Your BUT Good-Bye : How To Get Beyond the One Word That Stands Between You and Success
"Imagine a workplace where every employee is aware of the things they do - or fail to - that prevent them from being more productive and valuable. Imagine a company where everyone speaks openly and honestly about their weaknesses and are committed to strengthening and overcoming them. Imagine an environment where colleagues help each other become more efficient and less disruptive by speaking the truth about what detracts from the team's effort and objectives. Imagine a place where the firm's most talented employees know exactly what they need to do to attain a leadership position. This is no fantasy workplace, it can be your business if you listen to Joseph Azelby and Robert Azelby.
- Paperback | 224 pages
- 136 x 206 x 18mm | 200g
- 24 Jun 2013
- HarperCollins Publishers Inc
- New York, United States
- International ed.
Other books in this series
"Every successful leader knows that shortcomings in performance, if left unaddressed, limit professional growth. With humor and practical wisdom, this book shows you how to identify and strengthen your weak spots. Read it if you want to say hello to new career opportunities." -- Marshall Goldsmith, the world's leading executive coach & bestselling author of What Got You Here Won't Get You There "The Azelbys provide practical and powerful insights into how you can acknowledge and fix those things that may be limiting your career opportunities. No ifs, ands, or BUTs." -- Clayton Rose, Professor of Management Practice, Harvard Business School
About Joseph Azelby
Joe Azelby is the managing director and CEO of the Global Real Assets Group of a large financial firm, leading a team of more than 400 investment professionals. A graduate of Harvard University, he earned an MBA in finance from NYU's Stern School of Business. While at Harvard, he was the captain of the football team and then went on to play professionally with the Buffalo Bills. Bob Azelby is the vice president and general manager of the oncology unit of a large West Coast biotechnology firm, overseeing more than 500 sales and marketing personnel and responsible for more than $5 billion in annual revenue. He received his undergraduate degrees in economics and religious studies from the University of Virginia and his MBA from Harvard University.